Decode Health was recently recognized with an AI Innovator Award at the DataRobot AIX 22 global virtual conference. DataRobot is a Boston-based AI cloud platform company that works with customers worldwide across industries and verticals, including almost 40% of Fortune 50 companies.
Autoimmune diseases, such as multiple sclerosis (MS), ulcerative colitis, Crohn’s disease, and rheumatoid arthritis, are complex diseases that affect over four million people in the United States and cost the healthcare system over $90 billion [read more...]
Built on the SDOH modeling framework to incorporate vaccination data, showing >90% prediction accuracy across 13 time points. Tracked how vaccination rates reshaped the relative importance of demographic, socioeconomic, and environmental risk factors over time.
ML models achieving >90% accuracy for predicting COVID-19 case growth using social determinants of health data. Demonstrated how racial and ethnic risk factors shifted dynamically over time across counties.
According to an article in the Journal of the American Medical Association (JAMA), two Harvard economists estimate the cumulative financial costs of the COVID-19 pandemic at more than $16 trillion. To put this number into perspective, that’s approximately 90% of annual GDP of the United States or $200,000 for a family of four. This is a combination of lost income due to the COVID-induced recession and the economic effect of a shorter, less healthy life.
Just as national health officials warned ahead of the holiday season, the winter months of 2020-21 have proven to be the most challenging period of the COVID-19 pandemic so far. In Tennessee alone, there have [read more...]
As featured on tennesseelookout.com Decode Health had been subleasing office space in Cummins Station in Nashville when Covid-19 forced the team home in March. The company, which provides predictive disease insights to national laboratories, moved [read more...]
Although COVID-19 hospitalizations and death rates have dominated the media, another challenge has quietly emerged during the pandemic. Some COVID patients are reporting a wide variety of debilitating symptoms, often lasting months after being diagnosed. [read more...]
New members bring cross-industry insights to the company Nashville, Tenn. – Nov. 11, 2020 – Chase Spurlock, PhD, founder and CEO of Decode Health, announced the addition of two members to the company's Strategic Advisory Board. [read more...]
One-year-old technology startup Decode Health has developed a predictive artificial intelligence platform that identifies emerging trends in the COVID-19 outbreak, providing governments and other organizations early insights to where resources need to be allocated to provide targeted outreach among high-risk populations.
Precision medicine R&D platform
© DECODE HEALTH. ALL RIGHTS RESERVED | PRIVACY POLICY | FCOI Policy